1. Home
  2. VSTM

VSTM

Verastem Inc.

Logo Verastem Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-15-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Founded: 2010 Country:
United States
United States
Employees: N/A City: NEEDHAM
Market Cap: 285.8M IPO Year: 2012
Target Price: $28.79 AVG Volume (30 days): 149.6K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.96 EPS Growth: N/A
52 Week Low/High: $4.32 - $15.12 Next Earning Date: 05-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: